Tzingounis 1982.
Methods | Randomized, placebo‐controlled trial; 2 parallel groups. Unit of randomization: individual. |
|
Participants | Date of data collection: not reported. Setting: Alexandra Maternity Hospital, Athens, Greece. Inclusion criteria: women in labor (non‐elective). N = 96. Exclusion criteria: acute bleeding due to abruptio placentae, established infection. |
|
Interventions |
Intervention: 2nd generation cephalosporin:
Comparison: placebo:
|
|
Outcomes | Febrile morbidity (oral temperature of > 100.3oF twice 6 hrs apart) and infection of endometrium, urinary tract and wound (not defined); results of duration of maternal stay only provided for febrile patients. | |
Notes | No patients had any major complications from the use of cefuroxime. Class of antibiotic: 2nd generation cephalosporin. Subgroups:
|
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Quote: "Selected in a random manner". Comment: no description of sequence generation process. |
Allocation concealment (selection bias) | Unclear risk | Comment: no information was provided. |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Comment: no loss to follow‐up; no participants excluded. ITT analysis. |
Selective reporting (reporting bias) | Unclear risk | Comment: insufficient information to judge. |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Quote: "double‐blind".... "the placebo was comparable to cefuroxime in both appearance and viscosity of solution". |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Comment: insufficient information to judge. |
Other bias | Low risk | Comment: no other sources of bias identified. |